GNAT3
gene geneOn this page
Also known as gustducinGDCA
Summary
GNAT3 (G protein subunit alpha transducin 3, HGNC:22800) is a protein-coding gene on chromosome 7q21.11, encoding Guanine nucleotide-binding protein G(t) subunit alpha-3 (A8MTJ3). Guanine nucleotide-binding protein (G protein) alpha subunit playing a prominent role in bitter and sweet taste transduction as well as in umami (monosodium glutamate, monopotassium glutamate, and inosine monophosphate) taste transduction.
Sweet, bitter, and umami tastes are transmitted from taste receptors by a specific guanine nucleotide binding protein. The protein encoded by this gene is the alpha subunit of this heterotrimeric G protein, which is found not only in the oral epithelium but also in gut tissues. Variations in this gene have been linked to metabolic syndrome.
Source: NCBI Gene 346562 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 51 total
- MANE Select transcript:
NM_001102386
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22800 |
| Approved symbol | GNAT3 |
| Name | G protein subunit alpha transducin 3 |
| Location | 7q21.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | gustducin, GDCA |
| Ensembl gene | ENSG00000214415 |
| Ensembl biotype | protein_coding |
| OMIM | 139395 |
| Entrez | 346562 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000398291
RefSeq mRNA: 1 — MANE Select: NM_001102386
NM_001102386
CCDS: CCDS47625
Canonical transcript exons
ENST00000398291 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001532501 | 80458635 | 80458861 |
| ENSE00001532507 | 80462159 | 80462312 |
| ENSE00001532515 | 80474251 | 80474379 |
| ENSE00001532519 | 80478841 | 80478998 |
| ENSE00001532523 | 80488535 | 80488676 |
| ENSE00001532527 | 80494605 | 80494647 |
| ENSE00001532532 | 80511809 | 80512064 |
| ENSE00001597423 | 80462502 | 80462631 |
Expression profiles
Bgee: expression breadth broad, 27 present calls, max score 78.78.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1938 / max 173.6909, expressed in 21 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 84516 | 0.1606 | 20 |
| 84515 | 0.0245 | 7 |
| 84517 | 0.0087 | 3 |
Top tissues by expression
260 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.78 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 57.10 | gold quality |
| tibialis anterior | UBERON:0001385 | 56.97 | silver quality |
| ileal mucosa | UBERON:0000331 | 56.40 | silver quality |
| pancreatic ductal cell | CL:0002079 | 54.45 | silver quality |
| duodenum | UBERON:0002114 | 52.75 | gold quality |
| deltoid | UBERON:0001476 | 52.52 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 50.24 | gold quality |
| quadriceps femoris | UBERON:0001377 | 49.37 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.25 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.04 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.00 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 47.92 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 47.80 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 47.45 | gold quality |
| thymus | UBERON:0002370 | 47.42 | gold quality |
| kidney epithelium | UBERON:0004819 | 47.39 | gold quality |
| nephron tubule | UBERON:0001231 | 47.30 | gold quality |
| diaphragm | UBERON:0001103 | 47.05 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-11 | yes | 176.92 |
| E-ANND-3 | no | 2.10 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): GLI3
Literature-anchored findings (GeneRIF, showing 8)
- the alpha-subunit of the taste-specific G protein gustducin is expressed prominently in cells of the human colon (PMID:16728727)
- Axonemal-associated localization within the midpiece and principal piece of human spermatozoa raises the possibility that this G protein alpha-subunit may process intracellular signals controlling sperm motility. (PMID:17021831)
- The sweet taste receptors (alpha-gustducin and T1R3) are involved in glucose-stimulated secretion of GLP-1 and PYY. (PMID:21324568)
- (GNAT3, 11 SNPs) gene, located within the 1-LOD support interval region for their association with MS and its related traits. Several SNPs were associated with MS and its related traits. Remarkably. (PMID:22456541)
- Oral Microbiota Profile Associates with Sugar Intake and Taste Preference Genes. (PMID:32138214)
- Intestinal alteration of alpha-gustducin and sweet taste signaling pathway in metabolic diseases is partly rescued after weight loss and diabetes remission. (PMID:34338041)
- Candidate Gene of NOS3, MMP3, AGT, and AGT1R and Pathway Analyses for Platelet Reactivity and Clinical Outcomes of Repeat Revascularization After First PCI in Chinese Patients. (PMID:34860335)
- Worldwide diversity, association potential, and natural selection in the superimposed taste genes, CD36 and GNAT3. (PMID:34972209)
Cross-species orthologs
26 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gna15.1 | ENSDARG00000016364 |
| danio_rerio | gna15.2 | ENSDARG00000056654 |
| danio_rerio | gna15.4 | ENSDARG00000071416 |
| danio_rerio | si:ch211-207c7.2 | ENSDARG00000092481 |
| danio_rerio | gna15.3 | ENSDARG00000092948 |
| danio_rerio | ENSDARG00000116003 | |
| mus_musculus | Gnat3 | ENSMUSG00000028777 |
| rattus_norvegicus | Gnat3 | ENSRNOG00000005268 |
| drosophila_melanogaster | cta | FBGN0000384 |
| drosophila_melanogaster | Galphai | FBGN0001104 |
| drosophila_melanogaster | Galphaf | FBGN0010223 |
| drosophila_melanogaster | CG17760 | FBGN0033756 |
| drosophila_melanogaster | CG30054 | FBGN0050054 |
| caenorhabditis_elegans | WBGENE00001664 | |
| caenorhabditis_elegans | WBGENE00001665 | |
| caenorhabditis_elegans | WBGENE00001666 | |
| caenorhabditis_elegans | WBGENE00001667 | |
| caenorhabditis_elegans | WBGENE00001668 | |
| caenorhabditis_elegans | WBGENE00001670 | |
| caenorhabditis_elegans | WBGENE00001671 | |
| caenorhabditis_elegans | WBGENE00001673 | |
| caenorhabditis_elegans | WBGENE00001674 | |
| caenorhabditis_elegans | WBGENE00001675 | |
| caenorhabditis_elegans | gpa-14 | WBGENE00001676 |
| caenorhabditis_elegans | gpa-16 | WBGENE00001678 |
| caenorhabditis_elegans | gsa-1 | WBGENE00001745 |
Paralogs (15): GNA15 (ENSG00000060558), GNAI3 (ENSG00000065135), GNAO1 (ENSG00000087258), GNAS (ENSG00000087460), GNA11 (ENSG00000088256), GNAT1 (ENSG00000114349), GNAI2 (ENSG00000114353), GNA13 (ENSG00000120063), GNAI1 (ENSG00000127955), GNAZ (ENSG00000128266), GNAT2 (ENSG00000134183), GNAL (ENSG00000141404), GNA12 (ENSG00000146535), GNA14 (ENSG00000156049), GNAQ (ENSG00000156052)
Protein
Protein identifiers
Guanine nucleotide-binding protein G(t) subunit alpha-3 — A8MTJ3 (reviewed: A8MTJ3)
Alternative names: Gustducin alpha-3 chain
All UniProt accessions (1): A8MTJ3
UniProt curated annotations — full annotation on UniProt →
Function. Guanine nucleotide-binding protein (G protein) alpha subunit playing a prominent role in bitter and sweet taste transduction as well as in umami (monosodium glutamate, monopotassium glutamate, and inosine monophosphate) taste transduction. Transduction by this alpha subunit involves coupling of specific cell-surface receptors with a cGMP-phosphodiesterase; Activation of phosphodiesterase lowers intracellular levels of cAMP and cGMP which may open a cyclic nucleotide-suppressible cation channel leading to influx of calcium, ultimately leading to release of neurotransmitter. Indeed, denatonium and strychnine induce transient reduction in cAMP and cGMP in taste tissue, whereas this decrease is inhibited by GNAT3 antibody. Gustducin heterotrimer transduces response to bitter and sweet compounds via regulation of phosphodiesterase for alpha subunit, as well as via activation of phospholipase C for beta and gamma subunits, with ultimate increase inositol trisphosphate and increase of intracellular Calcium. GNAT3 can functionally couple to taste receptors to transmit intracellular signal: receptor heterodimer TAS1R2/TAS1R3 senses sweetness and TAS1R1/TAS1R3 transduces umami taste, whereas the T2R family GPCRs such as TAS2R14 act as bitter sensors. Also functions as lumenal sugar sensors in the gut to control the expression of the Na+-glucose transporter SGLT1 in response to dietaty sugar, as well as the secretion of Glucagon-like peptide-1, GLP-1 and glucose-dependent insulinotropic polypeptide, GIP. Thus, may modulate the gut capacity to absorb sugars, with implications in malabsorption syndromes and diet-related disorders including diabetes and obesity.
Subunit / interactions. G proteins are composed of 3 units; alpha, beta and gamma, respectively GNAT3, GNB1 and GNG13 for Gustducin heterotrimer for bitter taste transduction. The alpha chain contains the guanine nucleotide binding site. Component of the TAS2R14-GNAT3 complex, consisting of TAS2R14, GNAT3, GNB1 and GNG2; within the complex interacts with TAS2R14; this complex plays a role in the perception of bitterness. Gustducin heterotrimer may also be composed of GNAT3, GNB3 and GNG13.
Subcellular location. Cytoplasm.
Tissue specificity. Expressed in taste buds (sensory organs of clustered epithelial cells) of the circumvallate and foliate papillae of the tongue at protein level. Expressed in enteroendocrine L cells of the gut. Detected also in spermatozoa.
Post-translational modifications. Potential N-myristoylation may anchor alpha-subunit to the inner surface of plasma membrane.
Similarity. Belongs to the G-alpha family. G(i/o/t/z) subfamily.
RefSeq proteins (1): NP_001095856* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001019 | Gprotein_alpha_su | Family |
| IPR001408 | Gprotein_alpha_I | Family |
| IPR011025 | GproteinA_insert | Homologous_superfamily |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
Pfam: PF00503
UniProt features (38 total): strand 10, helix 9, binding site 7, region of interest 6, initiator methionine 1, chain 1, lipid moiety-binding region 1, domain 1, turn 1, compositionally biased region 1
Structure
Experimental structures (PDB)
6 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8VY9 | ELECTRON MICROSCOPY | 2.88 |
| 8YKY | ELECTRON MICROSCOPY | 2.99 |
| 9M8K | ELECTRON MICROSCOPY | 3 |
| 9OXB | ELECTRON MICROSCOPY | 3 |
| 8RQL | ELECTRON MICROSCOPY | 3.03 |
| 8XQP | ELECTRON MICROSCOPY | 3.29 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MTJ3-F1 | 94.11 | 0.86 |
Antibody-complex structures (SAbDab): 4 — 8RQL, 8VY9, 8XQP, 8YKY
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (7): 40–47; 47; 175–181; 181; 200–204; 269–272; 326
Post-translational modifications (1): 2
Function
Pathways and Gene Ontology
Reactome pathways
10 pathways
| ID | Pathway |
|---|---|
| R-HSA-170670 | Adenylate cyclase inhibitory pathway |
| R-HSA-381771 | Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) |
| R-HSA-392170 | ADP signalling through P2Y purinoceptor 12 |
| R-HSA-418555 | G alpha (s) signalling events |
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-418597 | G alpha (z) signalling events |
| R-HSA-9009391 | Extra-nuclear estrogen signaling |
| R-HSA-9634597 | GPER1 signaling |
| R-HSA-9660821 | ADORA2B mediated anti-inflammatory cytokines production |
| R-HSA-9717207 | Sensory perception of sweet, bitter, and umami (glutamate) taste |
MSigDB gene sets: 98 (showing top):
GOCC_SECRETORY_GRANULE, REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION, REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_PHOTOTRANSDUCTION, GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_PHOTOTRANSDUCTION_VISIBLE_LIGHT, GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS, GOBP_RESPONSE_TO_RADIATION, GOBP_RESPONSE_TO_NICOTINE, GOBP_DETECTION_OF_LIGHT_STIMULUS, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, GOCC_APICAL_PLASMA_MEMBRANE, GOBP_DETECTION_OF_ABIOTIC_STIMULUS
GO Biological Process (10): adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188), phototransduction, visible light (GO:0007603), response to nicotine (GO:0035094), detection of light stimulus involved in visual perception (GO:0050908), sensory perception of bitter taste (GO:0050913), sensory perception of sweet taste (GO:0050916), sensory perception of umami taste (GO:0050917), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of taste (GO:0050909)
GO Molecular Function (7): G protein-coupled receptor binding (GO:0001664), GTPase activity (GO:0003924), GTP binding (GO:0005525), G-protein beta/gamma-subunit complex binding (GO:0031683), metal ion binding (GO:0046872), nucleotide binding (GO:0000166), guanyl nucleotide binding (GO:0019001)
GO Cellular Component (8): acrosomal vesicle (GO:0001669), cytoplasm (GO:0005737), heterotrimeric G-protein complex (GO:0005834), plasma membrane (GO:0005886), axoneme (GO:0005930), apical plasma membrane (GO:0016324), protein-containing complex (GO:0032991), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-9 pathways:
| Category | Pathways |
|---|---|
| GPCR downstream signalling | 3 |
| G-protein mediated events | 1 |
| Activation of GABAB receptors | 1 |
| Incretin synthesis, secretion, and inactivation | 1 |
| Signal amplification | 1 |
| ESR-mediated signaling | 1 |
| G alpha (s) signalling events | 1 |
| Anti-inflammatory response favouring Leishmania parasite infection | 1 |
| Sensory perception of taste | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| sensory perception of taste | 3 |
| cellular anatomical structure | 3 |
| adenylate cyclase activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| phototransduction | 1 |
| detection of visible light | 1 |
| response to chemical | 1 |
| visual perception | 1 |
| detection of light stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| signaling receptor binding | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| protein-containing complex binding | 1 |
| cation binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| purine nucleotide binding | 1 |
| secretory granule | 1 |
| intracellular anatomical structure | 1 |
| extrinsic component of cytoplasmic side of plasma membrane | 1 |
| plasma membrane protein complex | 1 |
| GTPase complex | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| apical part of cell | 1 |
| plasma membrane region | 1 |
| cellular_component | 1 |
Protein interactions and networks
STRING
1833 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GNAT3 | PLCB2 | Q00722 | 988 |
| GNAT3 | TAS1R3 | Q7RTX0 | 987 |
| GNAT3 | TAS1R2 | Q8TE23 | 987 |
| GNAT3 | TAS1R1 | Q7RTX1 | 960 |
| GNAT3 | TAS2R38 | P59533 | 953 |
| GNAT3 | TRPM5 | Q9NZQ8 | 946 |
| GNAT3 | TAS2R4 | Q9NYW5 | 918 |
| GNAT3 | TAS2R46 | P59540 | 907 |
| GNAT3 | TAS2R10 | Q9NYW0 | 904 |
| GNAT3 | SLC5A1 | P13866 | 896 |
| GNAT3 | TAS2R43 | P59537 | 882 |
| GNAT3 | TAS2R7 | Q9NYW3 | 880 |
| GNAT3 | TAS2R5 | Q9NYW4 | 871 |
| GNAT3 | TAS2R1 | Q9NYW7 | 852 |
| GNAT3 | TAS2R9 | Q9NYW1 | 842 |
| GNAT3 | TAS2R13 | Q9NYV9 | 842 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RAB5C | GNAT3 | psi-mi:“MI:0914”(association) | 0.530 |
| GNAI1 | GNAT3 | psi-mi:“MI:0914”(association) | 0.530 |
| Haus1 | GNAT3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| GNAT3 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| SNTA1 | GNAT3 | psi-mi:“MI:0914”(association) | 0.350 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| OTUD3 | GNAT3 | psi-mi:“MI:0914”(association) | 0.350 |
| ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (20): GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS), GNAT3 (Reconstituted Complex), GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS), GNAT3 (Affinity Capture-MS)
ESM2 similar proteins: A8MTJ3, B2RSH2, G1XJZ0, O13055, O14438, O15976, P04695, P04696, P04897, P04899, P08752, P08753, P08754, P0C7Q4, P10824, P10825, P11488, P16894, P19087, P20353, P20612, P27044, P28052, P29348, P38400, P38401, P38402, P38403, P38407, P38408, P41776, P50146, P50147, P50149, P51876, P63096, P63097, P87034, P87383, Q18434
Diamond homologs: A2Y3B5, A8MTJ3, B0XRA0, B2RSH2, O04278, O04279, O13055, O13315, O14438, O15976, O42784, O74227, O74259, O95837, P04695, P04696, P04897, P04899, P08239, P08752, P08753, P08754, P09471, P0C7Q4, P0CN96, P0CN97, P10824, P10825, P11488, P16378, P16894, P18064, P18872, P19087, P20353, P20612, P26981, P27044, P27045, P28051
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
51 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2014 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:80458861:CCT:C | acceptor_gain | 1.0000 |
| 7:80458863:T:C | acceptor_gain | 1.0000 |
| 7:80462324:C:CT | acceptor_gain | 1.0000 |
| 7:80462325:A:T | acceptor_gain | 1.0000 |
| 7:80478839:A:AC | donor_gain | 1.0000 |
| 7:80478840:C:CC | donor_gain | 1.0000 |
| 7:80478840:CTAAG:C | donor_gain | 1.0000 |
| 7:80488533:A:AC | donor_gain | 1.0000 |
| 7:80488534:C:CT | donor_gain | 1.0000 |
| 7:80488534:CTG:C | donor_gain | 1.0000 |
| 7:80488534:CTGCA:C | donor_gain | 1.0000 |
| 7:80494603:A:AC | donor_gain | 1.0000 |
| 7:80494604:C:CC | donor_gain | 1.0000 |
| 7:80458860:CCCT:C | acceptor_gain | 0.9900 |
| 7:80458863:T:TC | acceptor_gain | 0.9900 |
| 7:80462308:CTATT:C | acceptor_gain | 0.9900 |
| 7:80462313:C:CC | acceptor_gain | 0.9900 |
| 7:80462501:CCA:C | donor_gain | 0.9900 |
| 7:80475570:T:TA | donor_gain | 0.9900 |
| 7:80478844:G:C | donor_gain | 0.9900 |
| 7:80478996:CTC:C | acceptor_gain | 0.9900 |
| 7:80478997:TCCTA:T | acceptor_loss | 0.9900 |
| 7:80478998:CCTAG:C | acceptor_loss | 0.9900 |
| 7:80478999:C:CG | acceptor_loss | 0.9900 |
| 7:80479000:T:G | acceptor_loss | 0.9900 |
| 7:80487684:A:AG | acceptor_gain | 0.9900 |
| 7:80487685:G:GG | acceptor_gain | 0.9900 |
| 7:80487685:GCAA:G | acceptor_gain | 0.9900 |
| 7:80487778:GTGG:G | donor_gain | 0.9900 |
| 7:80488526:CATA:C | donor_loss | 0.9900 |
AlphaMissense
2367 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:80462223:T:A | K270N | 1.000 |
| 7:80462223:T:G | K270N | 1.000 |
| 7:80462224:T:A | K270I | 1.000 |
| 7:80462589:C:A | W211C | 1.000 |
| 7:80462589:C:G | W211C | 1.000 |
| 7:80462591:A:G | W211R | 1.000 |
| 7:80462591:A:T | W211R | 1.000 |
| 7:80462598:T:A | R208S | 1.000 |
| 7:80462598:T:G | R208S | 1.000 |
| 7:80462614:C:T | G203E | 1.000 |
| 7:80462615:C:G | G203R | 1.000 |
| 7:80462615:C:T | G203R | 1.000 |
| 7:80494628:T:A | K46N | 1.000 |
| 7:80494628:T:G | K46N | 1.000 |
| 7:80494629:T:A | K46I | 1.000 |
| 7:80494630:T:G | K46Q | 1.000 |
| 7:80494632:C:T | G45E | 1.000 |
| 7:80494633:C:A | G45W | 1.000 |
| 7:80494647:C:T | G40E | 1.000 |
| 7:80511809:C:G | G40R | 1.000 |
| 7:80511809:C:T | G40R | 1.000 |
| 7:80458693:A:G | L348P | 0.999 |
| 7:80458724:C:G | A338P | 0.999 |
| 7:80462226:G:C | N269K | 0.999 |
| 7:80462226:G:T | N269K | 0.999 |
| 7:80462236:A:G | L266P | 0.999 |
| 7:80462287:A:G | L249P | 0.999 |
| 7:80462295:G:C | S246R | 0.999 |
| 7:80462295:G:T | S246R | 0.999 |
| 7:80462297:T:G | S246R | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000054545 (7:80491301 C>A,T), RS1000097961 (7:80475946 G>C), RS1000133611 (7:80479705 T>C), RS1000208146 (7:80482465 TATTTTCTTTTTCTTTTTTCTTTC>T), RS1000215055 (7:80467428 C>T), RS1000259633 (7:80506810 T>C), RS1000278675 (7:80463399 G>A), RS1000314355 (7:80513194 T>G), RS1000357825 (7:80485522 T>A,G), RS1000413162 (7:80473218 C>A,T), RS1000455852 (7:80484422 C>A,G), RS1000484438 (7:80479900 C>A,T), RS1000493963 (7:80469335 G>A), RS1000497756 (7:80496255 T>C), RS1000548861 (7:80469109 T>C)
Disease associations
OMIM: gene MIM:139395 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003075_130 | Cognitive decline rate in late mild cognitive impairment | 1.000000e-06 |
| GCST003075_95 | Cognitive decline rate in late mild cognitive impairment | 3.000000e-08 |
| GCST003542_206 | Night sleep phenotypes | 3.000000e-06 |
| GCST005991_90 | Platelet count | 2.000000e-17 |
| GCST005992_31 | Mean corpuscular hemoglobin concentration | 4.000000e-11 |
| GCST005999_16 | Aspartate aminotransferase levels | 3.000000e-14 |
| GCST011351_11 | Aspartate aminotransferase levels | 1.000000e-12 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007710 | cognitive decline measurement |
| EFO:0004309 | platelet count |
| EFO:0004528 | mean corpuscular hemoglobin concentration |
| EFO:0004736 | aspartate aminotransferase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects splicing, decreases expression | 1 |
| denatonium | increases reaction, increases secretion | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Rotenone | decreases expression | 1 |
| 1-Methyl-4-phenylpyridinium | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.